Contact Novavax Customer Service

Novavax, Inc. is a clinical-stage biotechnology company. It specializes in the discovery and development of vaccines to prevent infectious diseases. Novavax was founded in 1987. The company is headquartered in Gaithersburg, Maryland, United States. There are also facilities in Rockville, Maryland and Uppsala, Sweden. They produce vaccine candidates to respond to both known and emerging disease threats. Novavax uses the proprietary recombinant nanoparticle vaccine technology. Novavax is traded on the NASDAQ under the ticker symbol NVAX. In 2020, Novavax started developing a Covid-19 vaccine, named NVX-CoV2373. The company cooperates with Emergent BioSolutions to conduct preclinical and early-stage human research on the coronavirus vaccine candidate. The vaccine contains the spike protein of the SARS-CoV-2 molecule. NVX‑CoV2373 establishes immunity to SARS-CoV-2, preventing the virus infection. Novavax is studying its COVID-19 vaccine candidate in human trials across the UK. In November 2020, the company is going to conduct the late-stage trials in the U.S. It plans to expand the Phase III trial to include up to 15,000 people. Novavax is not the only company that develops the Covid-19 vaccine in the world. AstraZeneca, Sanofi, and Eli Lilly And Company are among the major players in the global coronavirus vaccine race.